Skip to main content
Smart Investors Daily
Elevance Health Inc. logo

NASDAQ · ELV

Elevance Health Inc.

Healthcare · Medical - Healthcare Plans

$390.16

Down-$10.68 (-2.66%)

Updated Nov 20, 2026, 2:20 AM

SID Score

7.3/10

Composite research score

Smart Money

62/100

Neutral

Market cap
80.05B
P/E ratio
14.7
Dividend yield
1.75%
52-week range
$274.84 – $450.69
Volume
2.73M
Avg. volume
1.72M

Price performance · ELV

ELV price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

ELV closed at $390.16 after 21 trading sessions, down 12.38% for the selected period.

Last close
$390.16
Period change
-12.38%
Period low
$390.16
Period high
$446.28
Daily close
View OHLC price history
ELV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$402.23$404.015$383.17$390.162.73M
Nov 18, 2026$431.87$435.96$400.12$400.841.91M
Nov 17, 2026$438.00$440.14$431.62$433.931.18M
Nov 16, 2026$438.27$447.42$438.27$446.282.28M
Nov 13, 2026$432.18$433.665$420.81$429.69779.12K
Nov 12, 2026$433.78$435.00$427.13$429.90943.19K
Nov 11, 2026$428.94$430.54$422.00$429.48698.27K
Nov 10, 2026$419.73$429.79$418.03$429.65906.31K
Nov 9, 2026$427.30$428.51$416.60$418.251.4M
Nov 6, 2026$421.47$430.69$421.47$425.621.44M
Nov 5, 2026$440.00$448.54$424.78$432.002.11M
Nov 4, 2026$421.10$437.965$412.06$434.181.73M
Nov 3, 2026$412.82$420.00$411.46$413.75917.42K
Nov 2, 2026$421.34$424.11$406.90$413.602.18M
Oct 30, 2026$425.00$426.7714$416.47$420.071.29M
Oct 29, 2026$419.00$422.555$417.51$422.021.04M
Oct 28, 2026$419.68$424.58$411.31$414.411.19M
Oct 27, 2026$429.96$434.38$418.66$421.491.54M
Oct 26, 2026$441.30$442.245$429.84$431.321.44M
Oct 23, 2026$442.27$445.42$439.00$439.951.17M
Oct 22, 2026$432.56$449.95$431.20$445.281.43M

Latest ELV news

The latest Smart Investors Daily articles mentioning ELV.

ELV research

Overview

Company profile and research snapshot.

Company profile

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$389.63
Implied upside
—
Analysts
19
ELV recent ratings
DateFirmRatingTarget
Nov 18, 2026Argus ResearchBuy—
Oct 27, 2026Wells FargoOverweight—
Oct 23, 2026TD CowenBuy—
Oct 22, 2026BarclaysOverweight—
Oct 22, 2026RBC CapitalSector Perform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 27, 2026

Evaluating Elevance Health (ELV) After Prolonged Share Price Weakness And 17.3% Undervaluation Estimate

With no single headline event driving attention, Elevance Health (ELV) has drawn investor interest after a mixed share price record, including a 16.18% decline over the past year and a 27.89% decline over three years. See our latest analysis for Elevance Health. Recent trading has been soft, with a 7 day share price return of 7.22% and a year to date share price return decline of 8.81%, while the 1 year total shareholder return decline of 16.18% and 3 year total shareholder return decline of...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.